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Drugs during Pregnancy and Lactation: Treatment
Options and Risk Assessment, 2nd ed., by Christof
Schaefer, Paul Peters, and Richard K. Miller: Academic
Press, 2007.
Christof Schaefer, Paul Peters, and Richard K. Miller,
three outstanding reproductive toxicologists-teratologists,
are the editors of the book. The ﬁrst edition of this book
was published in 2001 and is one of several important
books that helped scientists obtain the literature that
deals with the risks of drugs and chemicals during preg-
nancy and lactation. Each of these books has a different
format and goal but the underlying basic tenant is pro-
viding you with a succinct or extensive review of the lit-
erature dealing with speciﬁc drugs and chemicals. One of
the early books that was published was the Catalog of Ter-
atogenic Agents by Thomas Shepard. Then followed the
reproductive toxicology reference books by Scialli et al.
(1995), Briggs et al. (2005), and the TERIS publication by
Friedman and Polifka (2000). There were two editions of
the latter book, 1992 and 2000. We also have Schardein’s
extensive text on Chemical Teratology. Dr. Schardein has
indicated that the book published in 2000 will be his last
effort in that endeavor. Sever and Brent (1986) were the
editors of the Teratology Society’s Project that resulted in
the publication of the Teratogen update. Each of these
books have a different format and so it is worthwhile to
have all of them in your library if you want to quickly
examine the literature that deals with drugs and chemi-
cals that may or may not affect the human embryo.
This particular text edited by Schaefer et al. (2007) is a
multiauthored text, in that the editors do not author
many of the chapters. I think it is important to list the
titles of the various chapters and sections to give the
reader an idea of how comprehensive this book is.
Chapter One is written by Miller et al. and is a compre-
hensive 24-page review of the subject of reproductive and
developmental toxicology. It is an excellent chapter, end-
ing with sections on communicating risks of drugs and
pregnancy and a list of teratology information centers.
Chapter Two is titled ‘‘Speciﬁc Drug Therapy during
Pregnancy.’’ There are many sections to this chapter and
it covers pages 28–822 so chapter two is the major effort
to this publication. Different individuals who are
respected members of the developmental biology and
reproductive toxicology community author each section.
Chapter Three is titled ‘‘General Commentary of Drug
Therapy and Drug Risk during Lactation’’ and it is writ-
ten by Ruth Lawrence and Christof Schaefer and covers
pages 609–620.
Chapter Four is titled ‘‘Speciﬁc Drug Therapy during
Lactation’’ and is written by Christof Schaefer and Ruth
Lawrence. There are 18 sections in chapter four dealing
with speciﬁc drug therapy during lactation and all of
them were written by Christof Schaefer and/or Ruth
Lawrence. The titles of these sections are:
1. Analgesics, antiphlogistics, and anesthetics (Christof
Schaefer)
2. Antiallergics, antiasthmatics, and antitussives
(Christof Schaefer)
3. Gastrointestinal drugs (Christof Schaefer)
4. Anti-infectives (Christof Schaefer)
5. Vaccines and immunoglobulins (Ruth Lawrence and
Christof Schaefer)
6. Cardiovascular drugs and diuretics (Christof Schae-
fer)
7. Anticoagulants and ﬁbrinolytics (Christof Schaefer)
8. Antiepileptics (Christof Schaefer)
9. Psychotropic drugs (Christof Schaefer)
10. Immunomodulating and antineoplastic agents
(Ruth Lawrence and Christof Schaefer)
11. Hormones and hormone antagonists (Christof
Schaefer)
12. Dermatological drugs and local therapeutics (Ruth
Lawrence and Christof Schaefer)
13. Alternative remedies, vitamins, and minerals (Ruth
Lawrence and Christof Schaefer)
14. Diagnostics (Ruth Lawrence and Christof Schaefer)
15. Infections (Ruth Lawrence and Christof Schaefer)
16. Recreational drugs (Ruth Lawrence Christof
Schaefer)
17. Plant toxins (Ruth Lawrence and Christof Schaefer)
18. Industrial chemicals and environmental contami-
nants (Christof Schaefer)
The developmental or teratogenic evaluation of the
drugs or chemicals has been primarily written by one or
at most two individuals. The summaries are brief but
well written and provide a conclusion that would be use-
ful to a physician looking for potential teratogenesis or
developmental toxicity of a drug.
The editors have obviously edited the text very well.
While it may be difﬁcult to ﬁnd the drug that you are
looking for by the action of the drug that is listed in the
various chapters, it is easy to ﬁnd the location of the dis-
cussion of the drug in the subject index. The subject
index, therefore, is a very valuable part of the book.
The chapter ‘‘Drugs during Pregnancy and Lactation’’
is a very comprehensive and well-written text dealing
with the subject’s title. One might ask do we need
another book that is a reference for drugs and chemicals
that may have developmental or reproductive toxicity?
I think the answer is yes. None of the books that have
been published are 100% complete with regard to all of
the drugs and chemicals and, therefore, if you cannot
ﬁnd your answer in one book there is a good chance that
you will ﬁnd it in another one. Therefore, the addition of
the text, which is now up-to-date since it was published
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in 2007, may provide answers for some teratology or
genetic counselors that they cannot ﬁnd in the other
books.
How do we compare all of the publications dealing
with reproductive and developmental toxicity of drugs
and chemicals as a source for obtaining preliminary in-
formation about your concern about a drug or chemical
exposure in one of your patients? We can compare the
various volumes because each has assets that the others
do not have. For instance, Shardein’s book on Chemically
Induced Birth Defects has an extensive bibliography. There
is also extensive reference to the animal literature in
Shardein’s book. However, the book was not written or
intended to provide you with a risk assessment of vari-
ous drugs and chemicals. None of this material is on the
Internet so you cannot access new data because they are
not being kept up-to-date.
The Catalog of Teratogenic Agents (Shepard) is just what
it says. Fortunately, the drugs or chemicals are listed in
alphabetical order so you do not need the index in order
to ﬁnd the agent that you want. The articles are brieﬂy
summarized and risk analysis is provided very infre-
quently. It gives the readers access to the literature to
perform their own risk analysis. Fortunately, this text is
on the Internet and is therefore kept up-to-date so the
Internet resource is very helpful in getting the latest liter-
ature pertaining to a particular drug or chemical.
Scialli et al.’s (1995) book has excellent reviews but
the drugs and chemicals are not listed by classiﬁcation
or in alphabetical order, but the index does list them in
alphabetical order. The TERIS publication and website
was created by Jan Friedman. The drugs and chemicals
are in alphabetical order in the book and index. The ma-
terial is kept up-to-date and the original authors of the
ﬁrst two editions have indicated that they do not plan
another printed edition. TERIS is unique in two ways.
The risk analysis is performed by a group of
scientists and the quality of the data is also evaluated.
Drs. Richard Miller and Thomas Shepard are members
of the TERIS group.
So why should the 2nd edition of this book edited
by Shafer et al. be welcomed to your bookshelf? As
mentioned previously, the editors produced a quality
product. They have selected well-known and respected
chapter authors and the important feature of this book is
that the drugs are collated by their therapeutic purposes.
This saves a great deal of time if you are comparing the
relative developmental risks of therapeutic categories,
i.e., antihistamines or sex steroids.
Robert L. Brent
Distinguished Professor of Pediatrics
Radiology and Pathology
Thomas Jefferson University
A.I. DuPont Hospital for Children
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